Skip to main content

Table 4 Reasons for discontinuing treatments (n = 528)

From: Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization

Treatment

Patient/Fear Risk

Inability to afford treatment

Inability to comply

Loss of efficacy

Side effects

 

n (%)

n (%)

n (%)

n (%)

n (%)

Total

30 (5.7)

28 (5.3)

13 (2.5)

314 (59.5)

143 (27.1)

Phototherapy

18 (54.5)

8 (24.2)

Oral systemics

81 (39.9)

98 (48.3)

Biologics

17 (5.8)

16 (5.5)

7 (2.4)

215 (73.6)

37 (12.7)

  1. n number of patients
  2. Patient counts hidden to comply with the HIPAA privacy rule. Additional cells hidden as needed to prevent recalculation of hidden values